Email
Print
Oligonucleotide Synthesis Market - Forecast(2024 - 2030)
1. Oligonucleotide Synthesis Market - Overview
1.1 Definitions and Scope
2. Oligonucleotide Synthesis Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Oligonucleotide Synthesis Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Oligonucleotide Synthesis Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Oligonucleotide Synthesis Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Oligonucleotide Synthesis Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Oligonucleotide Synthesis Market - Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Oligonucleotide Synthesis Market - By Product (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Oligonucleotides, by product type
8.3.1.1 Column-based oligos
8.3.1.2 Array-based oligos
8.3.2 Oligonucleotides, by nucleic acid type
8.3.2.1 DNA oligos
8.3.2.2 RNA oligos
8.3.3 Equipment/ Synthesizers
8.3.4 Reagents
8.3.5 Services
8.3.5.1 Oligo synthesis
8.3.5.1.1 25 nmol
8.3.5.1.2 50 nmol
8.3.5.1.3 200 nmol
8.3.5.1.4 1,000 nmol
8.3.5.1.5 10,000 nmol
8.3.5.2 Purification
8.3.5.3 Modification
9. Oligonucleotide Synthesis Market - By End User (Market Size -$Million / $Billion)
9.1 Pharmaceutical - Biotechnology Companies
9.2 Diagnostic Laboratories
9.3 Academic Research Institutes
10. Oligonucleotide Synthesis - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 PCR primers
10.3.2 PCR Assays - Panels
10.3.3 Sequencing
10.3.4 DNA Microarrays
10.3.5 Fluorescence In Situ Hybridization (FISH)
10.3.6 Antisense Oligonucleotides
10.3.7 Other Applications
11. Oligonucleotide Synthesis - By Geography (Market Size -$Million / $Billion)
11.1 Oligonucleotide Synthesis Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Oligonucleotide Synthesis- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Oligonucleotide Synthesis- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Oligonucleotide Synthesis - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Oligonucleotide Synthesis - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Oligonucleotide Synthesis Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Oligonucleotide Synthesis Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Oligonucleotide Synthesis Market - Key Company List by Country Premium
15. Oligonucleotide Synthesis Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Agilent Technology
15.3 Bio-Synthesis
15.4 Bioautomation
15.5 Biolegio B V
15.6 Ge Healthcare Dharmacon Inc
15.7 Integrated Dna Technologies, Inc
15.8 Kaneka Eurogentec S A
15.9 Lgc Biosearch Technology
15.10 Life Technology Corporation
15.11 Merck Kgaa
15.12 Merck Millipore
15.13 Sigma-Aldrich Co. Llc
15.14 Thermo Fisher Scientific, Inc
15.15 Company 15
15.16 Company 16 & More
16.1 Abbreviations
16.2 Sources
17. Oligonucleotide Synthesis Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Oligonucleotide Synthesis Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Oligonucleotide Synthesis Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Oligonucleotide Synthesis Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Oligonucleotide Synthesis Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Oligonucleotide Synthesis Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Oligonucleotide Synthesis Market - Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Oligonucleotide Synthesis Market - By Product (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
8.3.1 Oligonucleotides, by product type
8.3.1.1 Column-based oligos
8.3.1.2 Array-based oligos
8.3.2 Oligonucleotides, by nucleic acid type
8.3.2.1 DNA oligos
8.3.2.2 RNA oligos
8.3.3 Equipment/ Synthesizers
8.3.4 Reagents
8.3.5 Services
8.3.5.1 Oligo synthesis
8.3.5.1.1 25 nmol
8.3.5.1.2 50 nmol
8.3.5.1.3 200 nmol
8.3.5.1.4 1,000 nmol
8.3.5.1.5 10,000 nmol
8.3.5.2 Purification
8.3.5.3 Modification
9. Oligonucleotide Synthesis Market - By End User (Market Size -$Million / $Billion)
9.1 Pharmaceutical - Biotechnology Companies
9.2 Diagnostic Laboratories
9.3 Academic Research Institutes
10. Oligonucleotide Synthesis - By Application (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 PCR primers
10.3.2 PCR Assays - Panels
10.3.3 Sequencing
10.3.4 DNA Microarrays
10.3.5 Fluorescence In Situ Hybridization (FISH)
10.3.6 Antisense Oligonucleotides
10.3.7 Other Applications
11. Oligonucleotide Synthesis - By Geography (Market Size -$Million / $Billion)
11.1 Oligonucleotide Synthesis Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Oligonucleotide Synthesis- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Oligonucleotide Synthesis- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Oligonucleotide Synthesis - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Oligonucleotide Synthesis - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Oligonucleotide Synthesis Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Oligonucleotide Synthesis Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Oligonucleotide Synthesis Market - Key Company List by Country Premium
15. Oligonucleotide Synthesis Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Agilent Technology
15.3 Bio-Synthesis
15.4 Bioautomation
15.5 Biolegio B V
15.6 Ge Healthcare Dharmacon Inc
15.7 Integrated Dna Technologies, Inc
15.8 Kaneka Eurogentec S A
15.9 Lgc Biosearch Technology
15.10 Life Technology Corporation
15.11 Merck Kgaa
15.12 Merck Millipore
15.13 Sigma-Aldrich Co. Llc
15.14 Thermo Fisher Scientific, Inc
15.15 Company 15
15.16 Company 16 & More
*Financials would be provided on a best efforts basis for private companies
16. Oligonucleotide Synthesis Market - Appendix16.1 Abbreviations
16.2 Sources
17. Oligonucleotide Synthesis Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
LIST OF FIGURES
1.US Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)2.Canada Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
3.Mexico Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
4.Brazil Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
5.Argentina Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
6.Peru Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
7.Colombia Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
8.Chile Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
9.Rest of South America Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
10.UK Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
11.Germany Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
12.France Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
13.Italy Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
14.Spain Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
15.Rest of Europe Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
16.China Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
17.India Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
18.Japan Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
19.South Korea Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
20.South Africa Oligonucleotide Synthesis Market Revenue, 2023-2030 ($M)
21.North America Oligonucleotide Synthesis By Application
22.South America Oligonucleotide Synthesis By Application
23.Europe Oligonucleotide Synthesis By Application
24.APAC Oligonucleotide Synthesis By Application
25.MENA Oligonucleotide Synthesis By Application
26.Thermo Fisher Scientific, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Life Technology Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Merck Kgaa, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Sigma-Aldrich Co. Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Merck Millipore, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Ge Healthcare Dharmacon Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Agilent Technology, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Bio-Synthesis, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Kaneka Eurogentec S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Integrated Dna Technologies, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
36.Bioautomation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
37.Lgc Biosearch Technology, Sales /Revenue, 2015-2018 ($Mn/$Bn)
38.Biolegio B V, Sales /Revenue, 2015-2018 ($Mn/$Bn)